Literature DB >> 12145452

Depression in Alzheimer's disease might be associated with apolipoprotein E epsilon 4 allele frequency in women but not in men.

Thomas Müller-Thomsen1, Sönke Arlt, Stefanie Ganzer, Ulrike Mann, Reinhard Mass, Dieter Naber, Ulrike Beisiegel.   

Abstract

The association between depression and apolipoprotein E (apoE) was investigated in 137 out-patients with Alzheimer's disease. An ICD-10 diagnosis of depression was found in 21.1% of all patients. There was a good correlation between clinicians' diagnoses and blinded rating by the Montgomery-Asberg Depression Rating Scale (r = 0.70). In male patients, apoE 3/3 was detected in 34.1%, 3/4 in 38.6%, 4/4 in 13.6%, 2/4 in 6.8% and 2/3 in 6.8% of cases. In female patients, apoE 3/3 was detected in 35.5%, 3/4 in 45.2%, 4/4 in 12.8%, 2/4 in 3.2% and 2/3 in 3.2% of cases. When analyzing the variance of gene dosage effect, the frequency of the apoE epsilon 4 allele was significantly increased in depressed women but not in men. This effect remained stable in stepwise regression analysis when depression as the dependent variable was tested against the independent variables age, age of onset, duration of disease, cognitive status and years of school education. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12145452     DOI: 10.1159/000064926

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  8 in total

Review 1.  Pharmacogenomics and therapeutic prospects in dementia.

Authors:  Ramón Cacabelos
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03       Impact factor: 5.270

2.  Does the apolipoprotein E epsilon 4 genotype influence the expression of depression with cognitive impairment?

Authors:  Mohit P Chopra; Reid D Landes; Richard A Jones; Zach L Feldman; Cornelia Beck; Sue T Griffin
Journal:  Int J Geriatr Psychiatry       Date:  2009-06       Impact factor: 3.485

Review 3.  Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease.

Authors:  Ramón Cacabelos
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

4.  Resolving the relationship between ApolipoproteinE and depression.

Authors:  Michael A Slifer; Eden R Martin; John R Gilbert; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Neurosci Lett       Date:  2009-03-06       Impact factor: 3.046

5.  APOE genotype predicts depression in women with Alzheimer's disease: a retrospective study.

Authors:  Lisa Delano-Wood; Wes S Houston; Jennifer A Emond; Natalie L Marchant; David P Salmon; Dilip V Jeste; Leon J Thal; Mark W Bondi
Journal:  Int J Geriatr Psychiatry       Date:  2008-06       Impact factor: 3.485

6.  Trajectories of depression symptoms over time differ by APOE4 genotype in older adults with type 2 diabetes.

Authors:  Inbar Lavie; Michal Schnaider Beeri; Yuval Berman; Yonathan Schwartz; Laili Soleimani; Anthony Heymann; Ramit Ravona-Springer
Journal:  Int J Geriatr Psychiatry       Date:  2021-06-02       Impact factor: 3.485

7.  Neuropsychiatric Symptoms, Endophenotypes, and Syndromes in Late-Onset Alzheimer's Disease: Focus on APOE Gene.

Authors:  Francesco Panza; Davide Seripa; Grazia D'Onofrio; Vincenza Frisardi; Vincenzo Solfrizzi; Patrizia Mecocci; Alberto Pilotto
Journal:  Int J Alzheimers Dis       Date:  2011-04-07

Review 8.  The association of antidepressant drug usage with cognitive impairment or dementia, including Alzheimer disease: A systematic review and meta-analysis.

Authors:  John Moraros; Chijioke Nwankwo; Scott B Patten; Darrell D Mousseau
Journal:  Depress Anxiety       Date:  2016-12-28       Impact factor: 6.505

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.